Massive 21,000-Patient study launched to crack Lymphoma's code

NCT ID NCT04996706

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

Summary

This study aims to build a large, diverse group of 21,000 people newly diagnosed with non-Hodgkin lymphoma to learn what affects their long-term health. It will collect detailed health information, lifestyle factors, and biological samples over time, but does not test a new treatment. The goal is to discover patterns that can help doctors better predict outcomes and improve future care for lymphoma patients.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

MD Anderson Cancer Center

Houston, Texas, 77030, United States
Mayo Clinic

Rochester, Minnesota, 55902, United States
Mayo Clinic in Arizona

Scottsdale, Arizona, 85259, United States
Mayo Clinic in Florida

Jacksonville, Florida, 32224-9980, United States
University of Iowa

Iowa City, Iowa, 52242, United States
University of Miami: Sylvester Comprehensive Cancer Center

Miami, Florida, 33136, United States
University of Rochester Medical Center

Rochester, New York, 14642, United States
Washington University School of Medicine in St. Louis

St Louis, Missouri, 63110, United States
Weill Cornell Medical College

New York, New York, 10065, United States
Winship Cancer Institute of Emory University

Atlanta, Georgia, 30322, United States

Conditions

Explore the condition pages connected to this study.

LYMPHOMA, NON-HODGKIN